China Universal Asset Management Company’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,594
| Closed | -$18.6K | – | 532 |
|
|
2024
Q3 | $18.6K | Buy |
10,594
+4,139
| +64% | +$7.28K | ﹤0.01% | 406 |
|
|
2024
Q2 | $7.55K | Sell |
6,455
-4,003
| -38% | -$4.68K | ﹤0.01% | 402 |
|
|
2024
Q1 | $94.5K | Buy |
10,458
+4,151
| +66% | +$37.5K | 0.01% | 379 |
|
|
2023
Q4 | $68.6K | Buy |
6,307
+5,003
| +384% | +$54.4K | 0.01% | 331 |
|
|
2023
Q3 | $10.5K | Buy |
1,304
+642
| +97% | +$5.17K | ﹤0.01% | 342 |
|
|
2023
Q2 | $7.19K | Sell |
662
-10
| -1% | -$109 | ﹤0.01% | 338 |
|
|
2023
Q1 | $4.64K | Buy |
672
+187
| +39% | +$1.29K | ﹤0.01% | 372 |
|
|
2022
Q4 | $1.93K | Buy |
485
+136
| +39% | +$541 | ﹤0.01% | 375 |
|
|
2022
Q3 | $2K | Buy |
+349
| New | +$2K | ﹤0.01% | 372 |
|